+Compare
GILD
Stock ticker:
NASDAQ
AS OF
Aug 16, 03:24 PM (EDT)
Price
$66.13
Change
-$0.09 (-0.14%)
Capitalization
82.99B

GILD Gilead Sciences Forecast, Technical & Fundamental Analysis

a developer of therapeutic products and treatments for life threatening diseases
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Aug 15, 2022

GILD's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for GILD turned positive on August 04, 2022. Looking at past instances where GILD's MACD turned positive, the stock continued to rise in 30 of 51 cases over the following month. The odds of a continued upward trend are 59%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2022. You may want to consider a long position or call options on GILD as a result. In of 112 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

GILD moved above its 50-day moving average on August 08, 2022 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for GILD crossed bullishly above the 50-day moving average on August 12, 2022. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GILD advanced for three days, in of 299 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GILD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GILD broke above its upper Bollinger Band on August 15, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for GILD entered a downward trend on August 02, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.102) is normal, around the industry mean (5.398). P/E Ratio (20.243) is within average values for comparable stocks, (92.397). Projected Growth (PEG Ratio) (0.541) is also within normal values, averaging (3.283). GILD has a moderately high Dividend Yield (0.043) as compared to the industry average of (0.027). P/S Ratio (3.037) is also within normal values, averaging (3.775).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GILD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GILD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 64, placing this stock worse than average.

AI

View a ticker or compare two or three

GILD
Buy/Sell Ratings
 
 
Technical Analysis# Of IndicatorsAvg. Odds
   
   
 
AI
A.I. Advisor
published Earnings

GILD is expected to report earnings to fall 1.90% to $1.55 per share on October 27

Gilead Sciences GILD Stock Earnings Reports
Q3'22
Est.
$1.55
Q2'22
Beat
by $0.06
Q1'22
Beat
by $0.32
Q4'21
Missed
by $0.90
Q3'21
Beat
by $0.89
The last earnings report on August 02 showed earnings per share of $1.58, beating the estimate of $1.52. With 2.55M shares outstanding, the current market capitalization sits at 82.99B.
AI
A.I.Advisor
published Dividends

GILD paid dividends on June 29, 2022

Gilead Sciences GILD Stock Dividends
А dividend of $0.73 per share was paid with a record date of June 29, 2022, and an ex-dividend date of June 14, 2022. Read more...
AI
A.I. Advisor
published General Information

General Information

a developer of therapeutic products and treatments for life threatening diseases

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
333 Lakeside Drive
Phone
+1 650 574-3000
Employees
13600
Web
https://www.gilead.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDNS193.094.26
+2.26%
Cadence Design Systems
APLT1.370.03
+2.24%
Applied Therapeutics
GSM6.870.03
+0.44%
Ferroglobe PLC
ALTU9.95-0.01
-0.10%
Altitude Acquisition Corp
NEWR67.78-1.63
-2.35%
New Relic

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with AMGN. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then AMGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
+5.16%
AMGN - GILD
55%
Loosely correlated
+1.08%
BIIB - GILD
43%
Loosely correlated
+0.63%
JNJ - GILD
42%
Loosely correlated
+0.48%
NVS - GILD
41%
Loosely correlated
-0.35%
ABBV - GILD
41%
Loosely correlated
-0.22%
More